{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:22:25Z","timestamp":1761488545897},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,9,14]],"date-time":"2010-09-14T00:00:00Z","timestamp":1284422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00277-010-1070-6","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T11:20:49Z","timestamp":1284376849000},"page":"315-322","source":"Crossref","is-referenced-by-count":23,"title":["Hypoxia-inducible factors in mantle cell lymphoma: implication for an activated mTORC1\u2192HIF-1\u03b1 pathway"],"prefix":"10.1007","volume":"90","author":[{"given":"Pinelopi","family":"Argyriou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sotirios G.","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Varvara","family":"Panteleon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Psyrri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Bakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vassiliki","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aris","family":"Spathis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Economopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstathios","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theofanis","family":"Economopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Rontogianni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,14]]},"reference":[{"key":"1070_CR1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.blre.2009.03.001","volume":"23","author":"A Obrador-Hevia","year":"2009","unstructured":"Obrador-Hevia A, Fern\u00e1ndez de Mattos S, Villalonga P, Rodr\u00edguez J (2009) Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies. Blood Rev 23:205\u2013216","journal-title":"Blood Rev"},{"key":"1070_CR2","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2006-04-015586","volume":"108","author":"M Rudelius","year":"2006","unstructured":"Rudelius M, Pittaluga S, Nishizuka S, Pham TH, Fend F, Jaffe ES, Quintanilla-Martinez L, Raffeld M (2006) Constitutive activation of Akt contributes to the pathogenesis and survival of mantle cell lymphoma. Blood 108:1668\u20131676","journal-title":"Blood"},{"key":"1070_CR3","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.2353\/ajpath.2006.051078","volume":"169","author":"E Peponi","year":"2006","unstructured":"Peponi E, Drakos E, Reyes G, Leventaki V, Rassidakis GZ, Medeiros LJ (2006) Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma. Am J Pathol 169:2171\u20132180","journal-title":"Am J Pathol"},{"key":"1070_CR4","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1182\/blood-2007-07-103481","volume":"111","author":"J Dal Col","year":"2008","unstructured":"Dal Col J, Zancai P, Terrin L, Guidoboni M, Ponzoni M, Pavan A, Spina M, Bergamin S, Rizzo S, Tirelli U, De Rossi A, Doglioni C, Dolcetti R (2008) Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma. Blood 111:5142\u20135151","journal-title":"Blood"},{"key":"1070_CR5","doi-asserted-by":"crossref","first-page":"5724","DOI":"10.1158\/1078-0432.CCR-08-3215","volume":"15","author":"A Psyrri","year":"2009","unstructured":"Psyrri A, Papageorgiou S, Liakata E, Scorilas A, Rontogianni D, Kontos CK, Argyriou P, Pectasides D, Harhalakis N, Pappa V, Kolialexi A, Economopoulou C, Kontsioti F, Maratou E, Dimitriadis G, Economopoulou P, Economopoulos T (2009) Phosphatidylinositol 3\u2032-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma. Clin Cancer Res 15:5724\u20135732","journal-title":"Clin Cancer Res"},{"key":"1070_CR6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.mol.0000169352.35642.06","volume":"16","author":"GA Soliman","year":"2005","unstructured":"Soliman GA (2005) The mammalian target of rapamycin signaling network and gene regulation. Curr Opin Lipidol 16:317\u2013323","journal-title":"Curr Opin Lipidol"},{"key":"1070_CR7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","volume":"124","author":"S Wullschleger","year":"2006","unstructured":"Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124:471\u2013484","journal-title":"Cell"},{"key":"1070_CR8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.cellsig.2009.01.012","volume":"21","author":"EA Dunlop","year":"2009","unstructured":"Dunlop EA, Tee AR (2009) Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cell Signal 21:827\u2013835","journal-title":"Cell Signal"},{"key":"1070_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1756-8722-2-45","volume":"2","author":"R Yuan","year":"2009","unstructured":"Yuan R, Kay A, Berg WJ, Lebwohl D (2009) Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy. J Hematol Oncol 2:45","journal-title":"J Hematol Oncol"},{"key":"1070_CR10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC (2007) AKT\/PKB signaling: navigating downstream. Cell 129:1261\u20131274","journal-title":"Cell"},{"key":"1070_CR11","doi-asserted-by":"crossref","first-page":"34495","DOI":"10.1074\/jbc.C800170200","volume":"283","author":"A Toschi","year":"2008","unstructured":"Toschi A, Lee E, Gadir N, Ohh M, Foster DA (2008) Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J Biol Chem 283:34495\u201334499","journal-title":"J Biol Chem"},{"key":"1070_CR12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/cdd.2008.21","volume":"15","author":"EB Rankin","year":"2008","unstructured":"Rankin EB, Giaccia AJ (2008) The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 15:678\u2013685","journal-title":"Cell Death Differ"},{"key":"1070_CR13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.cdd.4402315","volume":"15","author":"K Lisy","year":"2008","unstructured":"Lisy K, Peet DJ (2008) Turn me on: regulating HIF transcriptional activity. Cell Death Differ 15:642\u2013649","journal-title":"Cell Death Differ"},{"key":"1070_CR14","doi-asserted-by":"crossref","first-page":"44966","DOI":"10.1074\/jbc.M305502200","volume":"278","author":"L Gunaratnam","year":"2003","unstructured":"Gunaratnam L, Morley M, Franovic A, de Paulsen N, Mekhail K, Parolin DA, Nakamura E, Lorimer IA, Lee S (2003) Hypoxia inducible factor activates the transforming growth factor-alpha\/epidermal growth factor receptor growth stimulatory pathway in VHL(\u2212\/\u2212) renal cell carcinoma cells. J Biol Chem 278:44966\u201344974","journal-title":"J Biol Chem"},{"key":"1070_CR15","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2353\/ajpath.2010.090123","volume":"176","author":"TD Cras Le","year":"2010","unstructured":"Le Cras TD, Korfhagen TR, Davidson C, Schmidt S, Fenchel M, Ikegami M, Whitsett JA, Hardie WD (2010) Inhibition of PI3K by PX-866 prevents transforming growth factor-alpha-induced pulmonary fibrosis. Am J Pathol 176:679\u2013686","journal-title":"Am J Pathol"},{"key":"1070_CR16","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","volume":"18","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, Witters LA, Ellisen LW, Kaelin WG Jr (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev 18:2893\u20132904","journal-title":"Genes Dev"},{"key":"1070_CR17","doi-asserted-by":"crossref","first-page":"e6206","DOI":"10.1371\/journal.pone.0006206","volume":"4","author":"F Pistollato","year":"2009","unstructured":"Pistollato F, Rampazzo E, Abbadi S, Della Puppa A, Scienza R, D'Avella D, Denaro L, Te Kronnie G, Panchision DM, Basso G (2009) Molecular mechanisms of HIF-1alpha modulation induced by oxygen tension and BMP2 in glioblastoma derived cells. PLoS ONE 4:e6206","journal-title":"PLoS ONE"},{"key":"1070_CR18","doi-asserted-by":"crossref","first-page":"13595","DOI":"10.1074\/jbc.C200694200","volume":"278","author":"D Chen","year":"2003","unstructured":"Chen D, Li M, Luo J, Gu W (2003) Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem 278:13595\u201313598","journal-title":"J Biol Chem"},{"key":"1070_CR19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.coph.2008.08.004","volume":"8","author":"TA Yap","year":"2008","unstructured":"Yap TA, Garrett MD, Walton MI, Raynaud F, de Bono JS, Workman P (2008) Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises. Curr Opin Pharmacol 8:393\u2013412","journal-title":"Curr Opin Pharmacol"},{"key":"1070_CR20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/sj.leu.2402824","volume":"17","author":"F Chang","year":"2003","unstructured":"Chang F, Lee JT, Navolanic PM, Steelman LS, Shelton JG, Blalock WL, Franklin RA, McCubrey JA (2003) Involvement of PI3K\/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17:590\u2013603","journal-title":"Leukemia"},{"key":"1070_CR21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/leu.2008.348","volume":"23","author":"E Drakos","year":"2009","unstructured":"Drakos E, Atsaves V, Li J, Leventaki V, Andreeff M, Medeiros LJ, Rassidakis GZ (2009) Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma. Leukemia 23:784\u2013790","journal-title":"Leukemia"},{"key":"1070_CR22","first-page":"229","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissue","author":"SH Swerdlow","year":"2008","unstructured":"Swerdlow SH, Campo E, Seto M, M\u00fcller-Hermelink HK (2008) Mantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffre ES, Pileri SA (eds) WHO classification of tumours of haematopoietic and lymphoid tissue. IARC, Lyon, pp 229\u2013232"},{"key":"1070_CR23","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/0008-5472.CAN-08-3014","volume":"69","author":"J Copp","year":"2009","unstructured":"Copp J, Manning G, Hunter T (2009) TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res 69:1821\u20131827","journal-title":"Cancer Res"},{"key":"1070_CR24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00726-008-0230-7","volume":"38","author":"M Rosner","year":"2010","unstructured":"Rosner M, Siegel N, Valli A, Fuchs C, Hengstschl\u00e4ger M (2010) mTOR phosphorylated at S2448 binds to raptor and rictor. Amino Acids 38:223\u2013228","journal-title":"Amino Acids"},{"key":"1070_CR25","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1464-410X.2009.08538.x","volume":"104","author":"B Dai","year":"2009","unstructured":"Dai B, Kong YY, Ye DW, Ma CG, Zhou X, Yao XD (2009) Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics. BJU Int 104:1009\u20131016","journal-title":"BJU Int"},{"key":"1070_CR26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hon.861","volume":"26","author":"A Giatromanolaki","year":"2008","unstructured":"Giatromanolaki A, Koukourakis MI, Pezzella F, Sivridis E, Turley H, Harris AL, Gatter KC (2008) Phosphorylated VEGFR2\/KDR receptors are widely expressed in B-cell non-Hodgkin\u2019s lymphomas and correlate with hypoxia inducible factor activation. Hematol Oncol 26:219\u2013224","journal-title":"Hematol Oncol"},{"key":"1070_CR27","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1055\/s-2004-831850","volume":"129","author":"P Went","year":"2004","unstructured":"Went P, Dellas T, Bourgau C, Maurer R, Augustin F, Tzankov A, Dirnhofer S (2004) Expression profile and prognostic significance of CD24, p53 and p21 in lymphomas. A tissue microarray study of over 600 non-Hodgkin lymphomas. Dtsch Med Wochenschr 129:2094\u20132099","journal-title":"Dtsch Med Wochenschr"},{"key":"1070_CR28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","volume":"2","author":"W Klapper","year":"2009","unstructured":"Klapper W, Hoster E, Determann O, Oschlies I, van der Laak J, Berger F, Bernd HW, Cabe\u00e7adas J, Campo E, Cogliatti S, Hansmann ML, Kluin PM, Kodet R, Krivolapov YA, Loddenkemper C, Stein H, M\u00f6ller P, Barth TE, M\u00fcller-Hermelink K, Rosenwald A, Ott G, Pileri S, Ralfkiaer E, Rymkiewicz G, van Krieken JH, Wacker HH, Unterhalt M, Hiddemann W, Dreyling M, for the European MCL Network (2009) Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL Network. J Hematop 2:103\u2013111","journal-title":"J Hematop"},{"key":"1070_CR29","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood-2007-10-117010","volume":"111","author":"O Determann","year":"2008","unstructured":"Determann O, Hoster E, Ott G, Wolfram Bernd H, Loddenkemper C, Leo Hansmann M, Barth TE, Unterhalt M, Hiddemann W, Dreyling M, Klapper W, European Mantle Cell Lymphoma Network and the German Low Grade Lymphoma Study Group (2008) European Mantle Cell Lymphoma Network and the German Low Grade Lymphoma Study Group. Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group. Blood 111:2385\u20132387","journal-title":"Blood"},{"key":"1070_CR30","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1128\/MCB.01665-08","volume":"29","author":"HA Acosta-Jaquez","year":"2009","unstructured":"Acosta-Jaquez HA, Keller JA, Foster KG, Ekim B, Soliman GA, Feener EP, Ballif BA, Fingar DC (2009) Site-specific mTOR phosphorylation promotes mTORC1-mediated signaling and cell growth. Mol Cell Biol 29:4308\u20134324","journal-title":"Mol Cell Biol"},{"key":"1070_CR31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ijc.20052","volume":"111","author":"DE Swinson","year":"2004","unstructured":"Swinson DE, Jones JL, Cox G, Richardson D, Harris AL, O'Byrne KJ (2004) Hypoxia-inducible factor-1 alpha in non small cell lung cancer: relation to growth factor, protease and apoptosis pathways. Int J Cancer 111:43\u201350","journal-title":"Int J Cancer"},{"key":"1070_CR32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.prp.2008.07.007","volume":"205","author":"FH Passam","year":"2009","unstructured":"Passam FH, Alexandrakis MG, Kafousi M, Fotinou M, Darivianaki K, Tsirakis G, Roussou PA, Stathopoulos EN, Siafakas NM (2009) Histological expression of angiogenic factors: VEGF, PDGFRalpha, and HIF-1alpha in Hodgkin lymphoma. Pathol Res Pract 205:11\u201320","journal-title":"Pathol Res Pract"},{"key":"1070_CR33","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1046\/j.1365-2559.2002.01357.x","volume":"40","author":"M Stewart","year":"2002","unstructured":"Stewart M, Talks K, Leek R, Turley H, Pezzella F, Harris A, Gatter K (2002) Expression of angiogenic factors and hypoxia inducible factors HIF 1, HIF 2 and CA IX in non-Hodgkin\u2019s lymphoma. Histopathology 40:253\u2013260","journal-title":"Histopathology"},{"key":"1070_CR34","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1365-2141.2008.07093.x","volume":"141","author":"AM Evens","year":"2008","unstructured":"Evens AM, Schumacker PT, Helenowski IB, Singh AT, Dokic D, Keswani A, Kordeluk E, Raji A, Winter JN, Jovanovic BD, Holmgren A, Nelson BP, Gordon LI (2008) Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family. Br J Haematol 141:676\u2013680","journal-title":"Br J Haematol"},{"key":"1070_CR35","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1200\/JCO.2009.24.1893","volume":"28","author":"AM Evens","year":"2010","unstructured":"Evens AM, Sehn LH, Farinha P, Nelson BP, Raji A, Lu Y, Brakman A, Parimi V, Winter JN, Schumacker PT, Gascoyne RD, Gordon LI (2010) Hypoxia-inducible factor-1 alpha expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP. J Clin Oncol 28:1017\u20131024","journal-title":"J Clin Oncol"},{"key":"1070_CR36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1447-0756.2009.01127.x","volume":"36","author":"M Miyazawa","year":"2010","unstructured":"Miyazawa M, Yasuda M, Fujita M, Hirabayashi K, Hirasawa T, Kajiwara H, Muramatsu T, Miyazaki S, Harasawa M, Matsui N, Ogane N, Murakami M, Mikami M, Yanase T, Osamura RY (2010) Granulosa cell tumor with activated mTOR-HIF-1alpha-VEGF pathway. J Obstet Gynaecol Res 36:448\u2013453","journal-title":"J Obstet Gynaecol Res"},{"key":"1070_CR37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1440-1827.2008.02320.x","volume":"59","author":"M Miyazawa","year":"2009","unstructured":"Miyazawa M, Yasuda M, Fujita M, Kajiwara H, Hirabayashi K, Takekoshi S, Hirasawa T, Murakami M, Ogane N, Kiguchi K, Ishiwata I, Mikami M, Osamura RY (2009) Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma. Pathol Int 59:19\u201327","journal-title":"Pathol Int"},{"key":"1070_CR38","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00428-008-0578-9","volume":"452","author":"AE Greijer","year":"2008","unstructured":"Greijer AE, Delis-van Diemen PM, Fijneman RJ, Giles RH, Voest EE, van Hinsbergh VW, Meijer GA (2008) Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum. Virchows Arch 452:535\u2013544","journal-title":"Virchows Arch"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-010-1070-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-010-1070-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-010-1070-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T05:50:15Z","timestamp":1559022615000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-010-1070-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,14]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["1070"],"URL":"https:\/\/doi.org\/10.1007\/s00277-010-1070-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,14]]}}}